drugset / Trial / NCT00654329
Dexmedetomidine vs Fentanyl for BMT
Phase 4
Completed
101 enrolled
Children's National Research Institute
Hospira, now a wholly owned subsidiary of Pfizer · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized controlled clinical trial to examine effects of intranasal dexmedetomidine, an α2-adrenorecptor agonist, on pain control and agitation in children undergoing BMT.
Timeline
- Start
- 2005-08
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 2 ug/kg | Intranasal |
| Comparator | Fentanyl | Other / unclassified | 2 ug/kg | Intranasal |